Frank A. Sedor

1.4k total citations
41 papers, 1.1k citations indexed

About

Frank A. Sedor is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Frank A. Sedor has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Epidemiology. Recurrent topics in Frank A. Sedor's work include Cancer therapeutics and mechanisms (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Metal complexes synthesis and properties (4 papers). Frank A. Sedor is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Metal complexes synthesis and properties (4 papers). Frank A. Sedor collaborates with scholars based in United States, United Kingdom and Germany. Frank A. Sedor's co-authors include John G. Toffaletti, Robert H. Christenson, Sihe Wang, Kiang-Teck J. Yeo, Alan H.B. Wu, Kent Lewandrowski, Fred S. Apple, Martin H. Kroll, Anthony W. Butch and Eugene G. Sander and has published in prestigious journals such as Journal of the American Chemical Society, Circulation and PEDIATRICS.

In The Last Decade

Frank A. Sedor

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank A. Sedor United States 16 441 167 152 136 132 41 1.1k
John A. Opsahl United States 17 457 1.0× 197 1.2× 72 0.5× 228 1.7× 200 1.5× 48 1.1k
N Pozet France 20 275 0.6× 176 1.1× 62 0.4× 259 1.9× 131 1.0× 86 1.1k
M Pfeffer United States 16 325 0.7× 229 1.4× 102 0.7× 449 3.3× 150 1.1× 28 1.3k
Sverre Landaas Norway 20 250 0.6× 220 1.3× 115 0.8× 52 0.4× 288 2.2× 45 1.2k
W P Leary South Africa 19 290 0.7× 243 1.5× 510 3.4× 80 0.6× 218 1.7× 82 1.5k
J Bayliss United Kingdom 16 858 1.9× 207 1.2× 100 0.7× 40 0.3× 148 1.1× 25 1.3k
Eytan Cohen Israel 18 188 0.4× 181 1.1× 139 0.9× 146 1.1× 164 1.2× 49 949
Joseph R. Benotti United States 16 731 1.7× 193 1.2× 70 0.5× 41 0.3× 167 1.3× 37 1.4k
W. A. Mahon Canada 24 161 0.4× 180 1.1× 149 1.0× 47 0.3× 146 1.1× 47 1.1k
Ellis Jacobs United States 14 237 0.5× 239 1.4× 73 0.5× 91 0.7× 90 0.7× 36 896

Countries citing papers authored by Frank A. Sedor

Since Specialization
Citations

This map shows the geographic impact of Frank A. Sedor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank A. Sedor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank A. Sedor more than expected).

Fields of papers citing papers by Frank A. Sedor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank A. Sedor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank A. Sedor. The network helps show where Frank A. Sedor may publish in the future.

Co-authorship network of co-authors of Frank A. Sedor

This figure shows the co-authorship network connecting the top 25 collaborators of Frank A. Sedor. A scholar is included among the top collaborators of Frank A. Sedor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank A. Sedor. Frank A. Sedor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hudson, Michael, Christopher M. O’Connor, Wendy A. Gattis, et al.. (2004). Implications of elevated cardiac troponin t in ambulatory patients with heart failure: a prospective analysis. American Heart Journal. 147(3). 546–552. 103 indexed citations
2.
Yeo, Kiang-Teck J., Alan H.B. Wu, Fred S. Apple, et al.. (2003). Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clinica Chimica Acta. 338(1-2). 107–115. 245 indexed citations
3.
Wang, Sihe, et al.. (2002). pH Effects on Measurements of Ionized Calcium and Ionized Magnesium in Blood. Archives of Pathology & Laboratory Medicine. 126(8). 947–950. 142 indexed citations
4.
Kaplan, Andrew L., et al.. (2000). Comparison of cardiac troponin T versus creatine kinase-mb for risk stratification in a chest pain evaluation unit. The American Journal of Cardiology. 85(7). 801–805. 45 indexed citations
5.
Sedor, Frank A., et al.. (1999). Cardiac troponin T levels in umbilical cord blood. American Journal of Obstetrics and Gynecology. 181(5). 1259–1262. 28 indexed citations
6.
Procop, Gary W., et al.. (1997). Laboratory Tests in Evaluation of Acute Febrile Illness in Pediatric Emergency Room Patients. American Journal of Clinical Pathology. 107(1). 114–121. 20 indexed citations
7.
Sedor, Frank A., et al.. (1996). Evaluation of the YSI 2300 glucose analyzer: Algorithm-corrected results are accurate and specific. Clinical Biochemistry. 29(1). 27–31. 28 indexed citations
8.
Loun, Bounthon, et al.. (1996). Adaptation of a Quantitative Immunoassay for Urine Myoglobin:Predictor in Detecting Renal Dysfunction. American Journal of Clinical Pathology. 105(4). 479–486. 15 indexed citations
9.
Petros, William P., et al.. (1995). Artifactual hypoglycemia associated with hematopoietic cytokines.. PubMed. 119(8). 713–6. 5 indexed citations
10.
Williams, C P, et al.. (1994). Stability of plasma lactate in vitro in the presence of antiglycolytic agents. Clinical Chemistry. 40(7). 1327–1330. 53 indexed citations
11.
Sedor, Frank A., et al.. (1988). Reflotron cholesterol measurement evaluated as a screening technique.. PubMed. 34(12). 2542–5. 11 indexed citations
12.
Sedor, Frank A., et al.. (1988). Reflotron cholesterol measurement evaluated as a screening technique.. Clinical Chemistry. 34(12). 2542–2545. 10 indexed citations
13.
Christenson, Robert H., et al.. (1987). Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin.. Clinical Chemistry. 33(4). 606–608. 28 indexed citations
14.
McLeod, A A, James E. Brown, Barbara B. Kitchell, et al.. (1984). Hemodynamic and metabolic responses to exercise after alpha1-, beta1-, and nonselective beta-adrenoceptor blockade in man. The American Journal of Medicine. 76(2). 97–100. 7 indexed citations
15.
Sedor, Frank A., et al.. (1984). Hemodynamic and metabolic responses to exercise after adrenoceptor blockade in humans. Journal of Applied Physiology. 56(3). 716–722. 24 indexed citations
16.
Vermeulen, T., Frank A. Sedor, & Sue Y.S. Kimm. (1983). Effect of water rinsing on sodium content of selected foods.. PubMed. 82(4). 394–6. 3 indexed citations
17.
Sedor, Frank A. & Eugene G. Sander. (1977). Inhibition of uricase by substituted pyrimidines. Biochemical and Biophysical Research Communications. 75(2). 406–413. 5 indexed citations
18.
Sander, Eugene G., et al.. (1976). The dehalogenation of the 5-halo-5,6-dihydrouracils. Bioorganic Chemistry. 5(3). 231–239. 6 indexed citations
19.
Bennett, Larry E., et al.. (1973). Enhanced acidity of protic chelate complexes. Inorganic Chemistry. 12(5). 1200–1203. 6 indexed citations
20.
Sedor, Frank A. & Eugene G. Sander. (1973). The effect of thiols on the dehalogenation of 5-iodo and 5-bromouracil. Biochemical and Biophysical Research Communications. 50(2). 328–336. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026